Program

Korea Standard Time
Local Time

Program

Updated as of June 11, 2021
It is based on the local time of Seoul, Korea. (UTC+9)



Thursday, June 17


Plenary Lecture 1
Date & Time 6/17(Thu) 09:40-10:20 Room Room A
Vaccines for cancer prevention and treatment
Mary L. (Nora) Disis (University of Washington, USA)


Symposium 01
Session Title Cancer epigenetics and its clinical applications
Date & Time 6/17(Thu) 10:30-12:10 Place Room A
1) Dynamics of epigenomes in response to therapy in breast cancer
Céline Vallot (Institut Curie, France)
2) DNA methylation mechanisms of the oncogenic histone H3.3-G34W
Anders Lindroth (National Cancer Center, Korea)
3) DNA demethylation therapy in solid tumors
Toshikazu Ushijima (National Cancer Center Research Institute, Japan)
4) Global methylation loss as a predictive marker for checkpoint blockade therapy
Jung Kyoon Choi (Korea Advanced Institute of Science and Technology)


Symposium 02
Session Title Non-invasive monitoring of minimal residual disease
Date & Time 6/17(Thu) 10:30-12:10 Place Room B
1) Development of ctDNA assay and future perspective
Duhee Bang (Yonsei University College of Science)
2) ctDNA testing methods and data analysis algorithm
Seung-Tae Lee (Yonsei University College of Medicine)
3) Clinical application of ctDNA in surgical field
Wonshik Han (Seoul National University College of Medicine)
4) AI based cancer screening and MRD detection using cfDNA-WGS
Eun-Hae Cho (Green Cross Genome)


Symposium 03
Session Title Multidisciplinary treatment for bone metastases
Date & Time 6/17(Thu) 10:30-12:10 Place Room C
1) Benefit and risk of surgical treatment of spinal metastasis
Naresh Kumar (National University Hospital, Singapore)
2) Radiotherapy for spinal metastasis: Benefit and risk of SBRT
Su Ssan Kim (University of Ulsan College of Medicine)
3) RANKL as a therapeutic target for bone metastasis
Kazuo Okamoto (The University of Tokyo, Japan)
4) BTA (bone targeted agents) in metastatic bone tumors
Jin-Hee Ahn (University of Ulsan College of Medicine)


Symposium 04
Session Title DNA damage response (DDR) treatment: Diagnostic approach and treatment resistance
Date & Time 6/17(Thu) 13:30-15:10 Place Room A
1) Targeting DDR pathways in cancer treatment and selection of the right patients
Seock-Ah Im (Seoul National University College of Medicine)
2) Clinical evidence of PARP inhibitors: Focusing on breast and ovarian cancer
Kyung Hae Jung (University of Ulsan College of Medicine)
3) Unraveling the immunogenicity of DNA damage and repair defects
Robert Samstein (Icahn School of Medicine at Mount Sinai, USA)
4) New DDR inhibitors and novel strategies for targeting DDR in cancer
Timothy A. Yap (MD Anderson Cancer Center, USA)


Symposium 05
Session Title Lymph node exploration in cancer surgery
Date & Time 6/17(Thu) 13:30-15:10 Place Room B
1) Sentinel lymph node biopsy in lung cancer surgery
Seong Yong Park (Yonsei University College of Medicine)
2) Technique and tool of sentinel lymph node biopsy and adequate extent of lymph node dissection in breast cancer surgery
Jun Woo Lee (Ewha Womans University Mokdong Hospital)
3) Gastric cancer surgery
Keun Won Ryu (National Cancer Center)
4) Melanoma surgery
Sandra L. Wong (Dartmouth-Hitchcock Medical Center, USA)


Symposium 06
Session Title Precision medicine and immunotherapy for pediatric cancer
Date & Time 6/17(Thu) 13:30-15:10 Place Room C
1) Lessons from NCI-COG Pediatric MATCH trial for pediatric precision medicine
Donald Williams Parsons (Baylor College of Medicine, Texas Children's Cancer and Hematology Centers, USA)
2) Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine release
Jeong A Park (Memorial Sloan Kettering Cancer Center, USA)
3) Molecular profiling of CNS tumors
Jae-Kyung Won (Seoul National University Hospital)
4) Recent advance in CAR-T therapy
Hyoung Jin Kang (Seoul National University College of Medicine)


Educational Session 1
Session Title Cancer proteogenomic atlas
Date & Time 6/17(Thu) 15:20-17:00 Room Room A
1) Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma
Michael A. Gillette (Broad Institute of MIT and Harvard, USA)
2) Proteogenomic characterization of diffuse gastric cancers
Daehee Hwang (Seoul National University College of Natural Sciences)
3) Proteogenomic landscape of clear cell renal cell carcinoma
Hui Zhang (Johns Hopkins University, USA)
4) Pharmaco-proteogenomic characterization of glioblastoma
Hyun Seok Kim (Yonsei University College of Medicine)


Educational Session 2 [KOR]
Session Title Organ-based hypofractionated radiotherapy
Date & Time 6/17(Thu) 15:20-17:00 Room Room B
1) Hypofractionated RT for breast cancer: From months to a week
Jun Won Kim (Gangnam Severance Hospital, Yonsei University College of Medicine)
2) Changing radiation fractionation scheme in hepatopancreaticobiliary cancers
Eui Kyu Chie (Seoul National University College of Medicine)
3) SBRT and hypofractionated RT for early stage lung cancer
Jae Myoung Noh (Sungkyunkwan University School of Medicine)
4) Pros and cons of hypofractionated RT to bone and brain metastasis
Kyubo Kim (Ewha Womans University College of Medicine)


Young Investigator Symposium [KOR]
Session Title Young Investigator Symposium
Date & Time 6/17(Thu) 15:20-17:00 Place Room C
1) Investigation on improving bioinformatic markers of cancer immunotherapy response by radio-chemotherapy
Shin Kim (Keimyung University School of Medicine)
2) Multidisciplinary approach in young women with breast cancer
Hee Jeong Kim (University of Ulsan College of Medicine)
3) Heterogeneity in tumor-infiltrating lymphocytes: Individualized strategy according to the tumor specificity
Galam Leem (Yonsei University College of Medicine)
4) Scientific validation and clinical application of lung cancer organoid
Chaeuk Chung (Chungnam National University College of Medicine)


Satellite Symposium 1 (AstraZeneca)
Session Title

Transforming therapeutic strategy from advanced to early stage EGFR-mutation positive NSCLC

Date & Time

6/17(Thu) 08:30-08:50

Place

Room C

Tae Min Kim (Seoul National University College of Medicine)


Satellite Symposium 2 (ONO/BMS)
Session Title

Recent update of CheckMate 9LA and CheckMate 227 pivotal trials in 1L NSCLC

Date & Time

6/17(Thu) 08:50-09:10

Place

Room C

Sun Min Lim (Yonsei University College of Medicine)


Satellite Symposium 3 (Yuhan)
Session Title

A new 3G EGFR TKI, lazertinib: Its audacious journey from bench to clinic

Date & Time

6/17(Thu) 09:10-09:30

Place Room C
Byoung Chul Cho (Yonsei University College of Medicine)


Satellite Symposium 4 (Pfizer)
Session Title

Overview of CDK4/6 inhibitors: From past to future

Date & Time

6/17(Thu) 12:50-13:20

Place Room A
Kyung-Hun Lee (Seoul National University College of Medicine)


Satellite Symposium 5 (MSD)
Session Title

Optimal combination therapy with pembrolizumab and TKIs for mRCC

Date & Time

6/17(Thu) 12:50-13:20

Place

Room B

Chan Kim (CHA University School of Medicine)


Satellite Symposium 6 (Sanofi)
Session Title

Current practice and new approaches with oxaliplatin in GI cancers

Date & Time

6/17(Thu) 12:50-13:20

Place

Room C

Hong Jae Chon (CHA University School of Medicine)


Outstanding Abstract Session
Date & Time

6/17(Thu) 08:30-09:30

Place

Room A

1) Integrative multi-omics profiling uncovers clinically available serum biomarkers to predict microvascular invasion in hepatocellular carcinoma
Sunghwan Lee (CHA Bundang Medical Center)
2) Longitudinal monitoring by next-generation sequencing of plasma cell-free DNA in ALK-rearranged NSCLC patients treated with ALK tyrosine kinase inhibitors
Minsuk Kwon (Ajou University School of Medicine)
3) Elective internal mammary node irradiation in women with node-positive breast cancer: Results of a randomized, phase 3 trial
Hwa Kyung Byun (Yonsei Cancer Center)


Oral Presentation 1 [KOR]
Date & Time

6/17(Thu) 08:30-09:30

Place

Room B

1) Development and in vivo evaluation of anti-CD19 chimeric antigen receptor (CAR)- T cells
Kyung-Nam Koh (Asan Medical Center)
2) Clinical implementation of next-generation sequencing (NGS) tests and NGS-based therapy: A real-world data in a tertiary hospital
Jin Won Kim (Seoul National University Bundang Hospital)
3) Next-generation sequencing based landscape of FGFR alterations in Korean patients from the K-MASTER project
Ah Reum Lim (Korea University Anam Hospital)
4) Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma
Seung Won Choi (Samsung Medical Center)
5) Phase II trial of combined durvalumab plus tremelimumab with proton therapy to boost the abscopal effect for recurrent or metastatic head and neck squamous cell carcinoma
Hana Kim (Samsung Medical Center)
6) Trend of lung cancer surgery, hospital selection and survival between 2005 and 2016
Dohun Kim (Chungbuk National University Hospital)




Friday, June 18


Plenary Lecture 2
Date & Time 6/18(Fri) 09:40-10:20 Room Room A
Dissecting tumor evolution
Tyler E. Jacks (Koch Institute for Integrative Cancer Research at MIT, USA)


Symposium 07
Joint Symposium of KCA & Korean Association of Immunologists (KAI)
Session Title Era of next generations cancer immunotherapy
Date & Time 6/18(Fri) 10:30-12:10 Place Room A
1) Addressing emerging challenges in cell therapy of cancer
Dario Campana (Yong Loo Lin School of Medicine, National University of Singapore, Singapore)
2) Effects of sequential and timely combination of a cancer nanovaccine with immune checkpoint blockade on tumor control
Sangyong Jon (Korea Advanced Institute of Science and Technology)
3) Cancer immunotherapy targeting the tumor microenvironment by recombinant cytokine and bispecific antibody
Seung-Woo Lee (Pohang University of Science and Technology)
4) Reprogrammed oncolytic adenovirus as cancer immune-therapeutic
Chae Ok Yun (Hanyang University College of Engineering)


Symposium 08
Session Title Surgical innovation in cancer
Date & Time 6/18(Fri) 10:30-12:10 Place Room B
1) Fluorescence-guided cancer surgery: Experience in hepatobiliary surgery and future perspective
Takeaki Ishizawa (University of Tokyo, Japan)
2) Intraoperative radiotherapy for pancreas cancer
Joon Seong Park (Gangnam Severance Hospital, Yonsei University College of Medicine)
3) AI prediction model for clinical outcomes of colorectal cancer
Ji Won Park (Seoul National University Hospital)
4) AI Imaging analysis of surgical video
Chang Wook Jeong (Seoul National University Hospital)


Symposium 09
Session Title Proton therapy and FLASH irradiation
Date & Time 6/18(Fri) 10:30-12:10 Place Room C
1) Proton therapy: What we know and do not know
Dongryul Oh (Sungkyunkwan University School of Medicine)
2) Introduction of FLASH radiotherapy: KIRAMS experiences
Won Il Jang (Korea Cancer Center Hospital)
3) Current technical challenges for FLASH proton therapy
Young Kyung Lim (National Cancer Center)
4) Synchrotron X-ray FLASH radiotherapy
Jong-Ki Kim (Daegu Catholic University School of Medicine)


Symposium 10
Session Title COVID-19 in cancer patients
Date & Time 6/18(Fri) 13:20-15:00 Place Room A
1) Recent updates in COVID-19 treatment and vaccines
Pyoeng Gyun Choe (Seoul National University College of Medicine)
2) Special risk of COVID-19 in cancer surgery
Vivian E. Strong (Memorial Sloan Kettering Cancer Center, USA)
3) COVID-19 vaccination recommendation for cancer patients
Yeon Hee Park (Sungkyunkwan University School of Medicine)
4) Panel Discussion: Influence of COVID-19 on cancer care in Asian countries
Kazuhiro Yoshida (Gifu University Graduate School of Medicine, Japan)
Ying Wang (China Anti-Cancer Association, China)
Purvish Parikh (Shalby Cancer and Research Institute, India)
Zeba Aziz (Hameed Latif Hospital, Pakistan)
Agus Rizal Ardy Hariandy Hamid (University of Indonesia, Indonesia)
Gloria R. Cristal-Luna (National Kidney and Transplant Institute, St. Lukes Medical Center, Philippines)


Symposium 11
Joint Symposium of KCA & Korean Society of Gynecologic Oncology (KSGO)
Session Title The evolving landscape for endometrial cancer treatment
Date & Time 6/18(Fri) 13:20-15:00 Place Room C
1) Diagnosis and molecular classification of endometrial cancer
Hyojin Kim (Seoul National University Bundang Hospital)
2) Treatment decision according to the integrated molecular markers
Mi-Kyung Kim (Ewha Womans University Mokdong Hospital)
3) Immune checkpoint inhibitor for recurrent setting of endometrial cancer
Yong Wha Moon (CHA University School of Medicine)
4) Immune checkpoint blockade combination in endometrial cancer
Jinhwa Hong (Korea University College of Medicine)


Educational Session 3 [KOR]
Session Title Overcoming resistance to targeted and immune therapies
Date & Time 6/18(Fri) 15:10-16:50 Room Room A
1) Determinants of response and intrinsic resistance to PD-1 blockade in metastatic GC
Jeeyun Lee (Sungkyunkwan University School of Medicine)
2) Overcoming resistance to anti-HER2 therapy
Tae-Yong Kim (Seoul National University College of Medicine)
3) Strategies to overcome therapeutic resistance in renal cell carcinoma
In-Ho Kim (The Catholic University of Korea College of Medicine)
4) Overcoming resistance to immunotherapy in combination with radiotherapy targeting the tumor microenvironment
Jee Suk Chang (Yonsei University College of Medicine)


Educational Session 4 [KOR]
Session Title Artificial intelligence in cancer imaging and digital pathology
Date & Time 6/18(Fri) 15:10-16:50 Room Room B
1) Basic principles of AI in cancer imaging
Hwiyoung Kim (Yonsei University College of Medicine)
2) Artificial intelligence in neuro-oncologic imaging
Ji Eun Park (Asan Medical Center)
3) AI approach in digital pathology
Yosep Chong (The Catholic University of Korea College of Medicine)
4) Whole-slide image analysis reveals quantitative landscape of tumor-immune microenvironment in colorectal cancers
Jeong Mo Bae (Seoul National University Hospital)


Symposium 12 [KOR]
ϰȸü
Session Title ϵ
Date & Time 6/18(Fri) 15:10-16:50 Place Room C
1) [Ǻ] K-Cancer Ȱ
濵 (Ǻ)
2) [ϼ] Ȱ Ȳ
ֱͼ (ϼͱϴпб)
3) [ΰǰ] ϰ Ȳ Ȱ
赿 (ΰǰ)
4) [K-MASTER] ü ӻ
ڰȭ (Ǵ)


Satellite Symposium 7 (Lilly)
Session Title

Real-world outcomes of ramucirumab plus paclitaxel in patients with advanced gastric cancer

Date & Time

6/18(Fri) 12:50-13:10

Place

Room A

Hye Sook Han (Chungbuk National University College of Medicine)


Satellite Symposium 8 (JEIL)
Session Title

TAS-102, for better treatment outcomes in metastatic colorectal cancer

Date & Time

6/18(Fri) 12:50-13:10

Place

Room B

Seung-Hoon Beom (Yonsei University College of Medicine)


Satellite Symposium 9 (Roche)
Session Title

IMPower 110; I'M Powered!......Empower treatment-naive NSCLC patients?

Date & Time

6/18(Fri) 12:50-13:10

Place

Room C

Dae Ho Lee (University of Ulsan College of Medicine)


International Session 1
Date & Time 6/18(Fri) 08:30-09:30 Place Room A
1) High mitogenic stimulus induced by VEGF or Notch inhibition arrests physiological and tumor angiogenesis
Sarita Saraswati (Centro Nacional de Investigaciones Cardiovasculares, Spain)
2) IL-33 signalling in gastro-intestinal cancers: Foe or friend?
Moritz Eissmann (Olivia Newton-John Cancer Research Institute and LaTrobe University, Australia)
3) Tumor-infiltrating bystander CD8+ T cells activated by IL-15 produce IFN-g and contribute to tumor control
Galam Leem (Yonsei University College of Medicine)
4) Whole-genome sequencing reveals comprehensive genomic profiles of radiation-induced sarcomas
Eunji Kim (Korea Institute of Radiological & Medical Sciences)
5) Targeting progesterone signaling prevents metastatic ovarian cancer
Chi-Heum Cho (Keimyung University Dongsan Hospital)
6) Tissue expression and prognostic roles of CXCL12 and CXCR4 in high-grade serous ovarian carcinoma
Se Ik Kim (Seoul National University Hospital)


International Session 2
Date & Time 6/18(Fri) 08:30-09:30 Place Room B
1) Branching clonal evolution is frequent and explains carcinogenesis and metastasis in gallbladder adenocarcinoma
Minsu Kang (Seoul National University Bundang Hospital)
2) Epithelial mesenchymal transition phenotype and peritumoral immune cell infiltration in advanced biliary tract cancer
Chung Ryul Oh (Asan Medical Center)
3) Co-targeting PARP and ATR in biliary tract cancer
Jeesun Yoon (Seoul National University Hospital)
4) A good prognosis of endocrine responsive tumors among residual invasive cancer after anti-HER2 therapy: CALGB 40601 (Alliance) and validation studies
Sung Gwe Ahn (Gangnam Severance Hospital)
5) Combination of bevacizumab plus atezolizumab who progressed on atezolizumab monotherapy in pretreated non-small cell lung cancer patients: An open-label, two-stage, phase II trial
Jiyun Lee (Samsung Medical Center)
6) Development and validation of a deep learning model based on CT simulator images to predict 5-year recurrence of stage IIIA-N2 non-small-cell lung cancer patients treated with surgery and postoperative radiotherapy
Zeliang Ma (Chinese Academy of Medical Sciences and Peking Union Medical College, China)


Oral Presentation 2 [KOR]
Date & Time

6/18(Fri) 08:30-09:30

Place

Room C

1) Genomic instability of circulating tumor DNA as a prognostic marker for pancreatic cancer: A prospective cohort study
Min Kyeong Kim (National Cancer Center)
2) The role of PDGFRA as a therapeutic target in young colorectal cancer patients
Tae Won Kim (Samsung Medical Center)
3) Development and validation of 18F-fluorodeoxyglucose metabolic parameter-based models for predicting recurrence after upfront surgery in synchronous colorectal liver metastasis: A multicenter study
Hyo Sang Lee (GangNeung Asan Hospital)
4) Clinical evaluation of a droplet digital PCR assay for detecting POLE mutations and molecular classification of endometrial cancer
Hyojin Kim (Seoul National University Bundang Hospital)
5) Dynamic change of plasma-derived exosomal PD-L1 expression and miRNA in patients with metastatic urothelial carcinoma who received immune checkpoint inhibitor
Joori Kim (Seoul St. Marys Hospital)


KCA-DDF International Gastric Cancer Educational Symposium
Opening
Date & Time

6/18(Fri) 08:00-08:15

Place

Room D

Opening remarks with introduction of KCA-DDF joint international gastric cancer educational symposium
Han-Kwang Yang, M.D., Ph.D. (Chairman, Board of Directors KCA)
Congratulatory remarks with Introduction of DDF & DDF Video
Andrea P. Eidelman, Esq. (DDF CEO)

Session 1
Session Title

How can we improve early screening methods worldwide?
[Role of Early Screening, Differences Around the World]

Date & Time

6/18(Fri) 08:15-09:00

Place

Room D

Moderators Yasuhiro Kodera (Chairman, Board of Directors, Japanese Gastric Cancer Association, Japan)
Daniel Catenacci (The University of Chicago Medicine Center, USA)
1) Gastric cancer screening in Korea: A successful story
Effectiveness of the Korean National Cancer Screening Program in reducing gastric cancer mortality

Kui Son Choi (National Cancer Center, Korea)
2) Gastric cancer screening in Japan
Nobutake Yamamichi (The University of Tokyo Hospital, Japan)
3) Gastric cancer screening in China
Qi Wu (Peking University Cancer Hospital & Institute, China)
4) Q&A and Panel Discussion
Panelists Kui Son Choi (Korea), Nobutake Yamamichi (Japan), Qi Wu (China),
Daniel Catenacci (USA), Kum Hei Ryu (National Cancer Center, Korea)
Family of Patient Hiromi Todoroki (Japan)

Session 2
Session Title

Would you discuss minimally invasive surgery for gastric cancer?
What are the best treatment options for me?
[Advantage vs Disadvantage: Conventional surgery vs. MIS vs. Robotic surgery]

Date & Time

6/18(Fri) 09:00-09:45

Place

Room D

Moderators Jae Moon Bae (Chairman, Board of Directors, Korean Gastric Cancer Association, Korea)
Jiafu Ji (Vice President, Board of Directors, Chinese Anti-Cancer Association)
1) Minimally invasive gastrectomy for gastric cancer
Sang-Uk Han (Ajou University Hospital)
2) How to choose between open, minimally invasive or robotic surgery in the management of gastric cancer
Raul Rosenthal (Cleveland Clinic Florida, USA)
3) Q&A and Panel Discussion
Patient Panelist Gabby Bouska (USA), Gabrielle Bouska (USA), Yudan Zhang (China)

Session 3
Session Title

What are the treatment options for metastatic disease? ]
[Understanding Systemic Treatment & New Clinical Trials for Gastric Cancer]

Date & Time

6/18(Fri) 09:45-10:30

Place

Room D

Moderators Yung-Jue Bang (Emeritus Professor, Seoul National University, College of Medicine, Korea)
David H. Ilson (Memorial Sloan Kettering Cancer Center, USA)
1) Gastric cancer: Advances in systemic therapy
David H. Ilson (Memorial Sloan Kettering Cancer Center, USA)
2) Treatment options for metastatic gastric cancer in the east
Min-Hee Ryu (Asan Medical Center)
3) Q&A and Panel Discussion
Patient Panelist Denise Leprine (USA), Chi Sang Won (Korea)


E-Poster Presentations
Posters are available for electronic viewing for participants.


top